David Bonita

General Partner atOrbiMedNew York

David Bonita is a General Partner at OrbiMed. He previously worked as a corporate finance analyst at Morgan Stanley and UBS.

What David can write

Writes checks of$1M to $30M+
Comes in atSeed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Email the firm[email protected]The firm's own inbox for founders.

OrbiMed writes $1M to $30M+ checks, larger than 83% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: OrbiMed.

Career

  1. Morgan Stanley · corporate finance analyst
  2. UBS · corporate finance analyst
  3. OrbiMed · General Partner
    Now

Investments named in public bios

Loxo OncologyTricidaCryterion MedicalTherachon SAS

Focus

healthcarebiopharmaceuticalmedical device

Education

Harvard University, A.B. in Biological SciencesColumbia University, M.D./M.B.A.

Also at OrbiMed

Partners like David

At firms with a similar stage, sector and check size.

Alert me when OrbiMed is active

One email when David's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is David Bonita?

David Bonita is a General Partner at OrbiMed. He previously worked as a corporate finance analyst at Morgan Stanley and UBS.

How much does David Bonita invest?

David Bonita invests through OrbiMed, which writes checks of $1M to $30M+ at seed, series a, series b.

How do I pitch David Bonita?

Email [email protected], the firm's inbox for founders, and name David in the subject. A warm intro from a founder OrbiMed backed works better.

What did David Bonita do before OrbiMed?

corporate finance analyst at Morgan Stanley; corporate finance analyst at UBS.

Last updated 2026-10-15. Is this you? Ask for a correction.